Advertisement
Britain s regulators today approved the Oxford/AstraZeneca Covid-19 vaccine, offering renewed hope the end of the pandemic could just be months away.
Officials said the jab will be made available from next week , while Health Secretary Matt Hancock claimed the approval now offers high confidence the UK could get out of this by spring .
It comes after Britain yesterday recorded more than 53,000 infections in record daily high amid fears hospitals may be overwhelmed by spiralling admissions within days.
Here, MailOnline answers all the questions about the jab including how it works, when it will be rolled out, and how many Britons could be able to get it every day.
More than 4,000 coronavirus heroes in Oxfordshire have been thanked for their role in fighting the pandemic by taking part in lifesaving research. A total of 4,366 patients and volunteers took part in 22 studies to help researchers prevent, diagnose and treat Covid-19. Since the pandemic began, the National Institute for Health Research (NIHR) has helped recruit more than 600,000 participants nationally to help with research, including 1,816 at Oxford University Hospitals NHS Foundation Trust, 527 at Oxford Health NHS Foundation Trust, 343 through Oxfordshire’s GP practices and 1,680 at the University of Oxford and local care homes. Prof Keith Channon, Director of Research and Development at Oxford University Hospitals, said: “The extraordinary progress in our understanding of Covid-19 – including how it is transmitted, how it affects the body, how it can be treated, and prevented – is a reflection of the scale, scope and speed of the many research studies and tria
Sarah Hurst
Sarah Hurst is a 47-year-old freelance journalist based outside of London, where she lives with her mother and 12-year-old daughter.
She was in AstraZeneca s UK trial for the COVID-19 vaccine, and left last week in protest at the company s announcement that they would work with Russia s Sputnik vaccine developers.
Hurst has been writing about Russia since 1990 and sees AstraZeneca s collaboration with Russia as unethical and ill-advised, particularly due to the lack of transparency around Sputnik s development. I was devastated. I felt betrayed. and furious that instead of working to bring more of Putin s killers to justice, some in the West apparently want to reward him, writes Hurst.
Edited by Branko Miletic
Fender Katsalidis is promoting three associate directors to principal level and is welcoming Rosie Morley and Megan Rodgers to the team, also as principals, with their areas of expertise relevant to the firm’s growth.
Mark Murphy, who has been with the practice for 10 years, will take on a new role as managing director.
Morley will be the new lead for Fender Katsalidis’ interiors team as the firm expands its interior design expertise to meet all client and project needs. She is based in Melbourne and will be servicing clients nationally.
“Fender Katsalidis is an iconic name in shaping the Australian architectural landscape and there is a real opportunity for this influence to continue to be carried through into interiors,” says Morley.